Potential role and therapeutic interests of myo-inositol in metabolic diseases
ML Croze, CO Soulage - Biochimie, 2013 - Elsevier
Several inositol isomers and in particular myo-inositol (MI) and D-chiro-inositol (DCI), were
shown to possess insulin-mimetic properties and to be efficient in lowering post-prandial …
shown to possess insulin-mimetic properties and to be efficient in lowering post-prandial …
Inositols in insulin signaling and glucose metabolism
A Bevilacqua, M Bizzarri - International journal of …, 2018 - Wiley Online Library
In the past decades, both the importance of inositol for human health and the complex
interaction between glucose and inositol have been the subject of increasing consideration …
interaction between glucose and inositol have been the subject of increasing consideration …
Myo-inositol effects in women with PCOS: a meta-analysis of randomized controlled trials
V Unfer, F Facchinetti, B Orrù, B Giordani… - Endocrine …, 2017 - ec.bioscientifica.com
Myo-inositol (MI) supplementation in women with polycystic ovary syndrome (PCOS) has
been evaluated over the last years. Many hormonal and reproductive impairments …
been evaluated over the last years. Many hormonal and reproductive impairments …
Pharmacodynamics and pharmacokinetics of inositol (s) in health and disease
M Bizzarri, A Fuso, S Dinicola, A Cucina… - Expert opinion on …, 2016 - Taylor & Francis
Introduction: Inositol and its derivatives comprise a huge field of biology. Myo-inositol is not
only a prominent component of membrane-incorporated phosphatidylinositol, but …
only a prominent component of membrane-incorporated phosphatidylinositol, but …
DCEO biotechnology: tools to design, construct, evaluate, and optimize the metabolic pathway for biosynthesis of chemicals
Chemical synthesis is a well established route for producing many chemicals on a large
scale, but some drawbacks still exist in this process, such as unstable intermediates …
scale, but some drawbacks still exist in this process, such as unstable intermediates …
Results from the International Consensus Conference on Myo-inositol and d-chiro-inositol in Obstetrics and Gynecology: the link between metabolic syndrome and …
F Facchinetti, M Bizzarri, S Benvenga, R D'Anna… - European Journal of …, 2015 - Elsevier
In recent years, interest has been focused to the study of the two major inositol
stereoisomers: myo-inositol (MI) and d-chiro-inositol (DCI), because of their involvement, as …
stereoisomers: myo-inositol (MI) and d-chiro-inositol (DCI), because of their involvement, as …
myo-Inositol Supplementation and Onset of Gestational Diabetes Mellitus in Pregnant Women With a Family History of Type 2 Diabetes: A prospective, randomized …
R D'Anna, A Scilipoti, D Giordano, C Caruso… - Diabetes …, 2013 - Am Diabetes Assoc
OBJECTIVE To check the hypothesis that myo-inositol supplementation may reduce
gestational diabetes mellitus (GDM) onset in pregnant women with a family history of type 2 …
gestational diabetes mellitus (GDM) onset in pregnant women with a family history of type 2 …
The effectiveness of Myo‐inositol and D‐chiro inositol treatment in type 2 diabetes
B Pintaudi, G Di Vieste… - International journal of …, 2016 - Wiley Online Library
Inositol has been used as a supplement in treating several pathologies such as PCOS,
metabolic syndrome, and gestational diabetes. Both myo‐inositol and its isomer d‐chiro …
metabolic syndrome, and gestational diabetes. Both myo‐inositol and its isomer d‐chiro …
Nutritional and acquired deficiencies in inositol bioavailability. Correlations with metabolic disorders
Communities eating a western-like diet, rich in fat, sugar and significantly deprived of fibers,
share a relevant increased risk of both metabolic and cancerous diseases. Even more …
share a relevant increased risk of both metabolic and cancerous diseases. Even more …
Inositol's and other nutraceuticals' synergistic actions counteract insulin resistance in polycystic ovarian syndrome and metabolic syndrome: state-of-the-art and future …
C Paul, AS Laganà, P Maniglio, O Triolo… - Gynecological …, 2016 - Taylor & Francis
The incidence of metabolic syndrome (MetS), type II diabetes (T2D) and polycystic ovarian
syndrome (PCOS) has been progressively increasing. Insulin resistance (InsR) seems to …
syndrome (PCOS) has been progressively increasing. Insulin resistance (InsR) seems to …